Skip to content
value.today

Micell Technologies Inc.

Total raised
$161 M
4 rounds on record
Latest round
$62 M
Sep 2017
First round on record
Jun 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Micell Technologies Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2017$62 MNo. 4$50 to $250 million

Micell Technologies Inc.: Raise no. 4, Sep 2017

Investors in this round

51 investors had bought by the notice of Sep 19, 2017: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$62 M of $70 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$28,040
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur J. Benvenuto · Executive Officer, Director
  • Timothy G. McMahon · Executive Officer
  • Archibald J. Cox · Director
  • John G. Lowry · Director
  • Kenneth G. Langone · Director
  • Michael G. Stansky · Director
  • Robert S. Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Invemed Associates LLC (CRD 6728) · New York, New YorkSold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV

Signed by Timothy McMahon, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 19, 2017. Read the notice at the SEC.

equity, debtSEC
Jun 2017$42 MNo. 3$10 to $50 million

Micell Technologies Inc.: Raise no. 3, Jun 2017

Investors in this round

51 investors had bought by the notice of Jun 21, 2017: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$42 M of $50 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$28,040
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur J. Benvenuto · Executive Officer, Director
  • Timothy G. McMahon · Executive Officer
  • Archibald J. Cox · Director
  • John G. Lowry · Director
  • Kenneth G. Langone · Director
  • Michael G. Stansky · Director
  • Robert S. Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Invemed Associates LLC (CRD 6728) · New York, New YorkSold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV

Signed by Arthur J. Benvenuto, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 21, 2017. Read the notice at the SEC.

equity, debtSEC
Mar 2017$32 MNo. 2$10 to $50 million

Micell Technologies Inc.: Raise no. 2, Mar 2017

Investors in this round

51 investors had bought by the notice of Apr 4, 2017: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $35 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$28,040
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur J. Benvenuto · Executive Officer, Director
  • Daniel G. Estay · Executive Officer, Director
  • Archibald J. Cox · Director
  • John G. Lowry · Director
  • Kenneth G. Langone · Director
  • Michael G. Stansky · Director
  • Robert S. Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Invemed Associates LLC (CRD 6728) · New York, New YorkSold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV

Signed by Arthur J. Benvenuto, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 4, 2017. Read the notice at the SEC.

equity, debtSEC
Jun 2016$26 MNo. 1$10 to $50 million

Micell Technologies Inc.: Raise no. 1, Jun 2016

Investors in this round

51 investors had bought by the notice of Nov 18, 2016: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $30 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$28,040
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur J. Benvenuto · Executive Officer, Director
  • Daniel G. Estay · Executive Officer, Director
  • James A. Klein · Executive Officer
  • Archibald A. Cox · Director
  • John G. Lowry · Director
  • Kenneth G. Langone · Director
  • Michael G. Stansky · Director
  • Robert S. Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Invemed Associates LLC (CRD 6728) · New York, New YorkSold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV

Signed by Arthur J. Benvenuto, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 18, 2016. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Micell Technologies Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2017).

    SEC Form D · Sep 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2017

That is all the official record says: Micell Technologies Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Micell Technologies Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 51 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Micell Technologies Inc.
NameRoleNamed in
Arthur J. BenvenutoExecutive officerSep 2017
Timothy G. McMahonExecutive officerSep 2017
Daniel G. EstayExecutive officerApr 2017
James A. KleinExecutive officerNov 2016
Archibald J. CoxDirectorSep 2017
Arthur J. BenvenutoDirectorSep 2017
John G. LowryDirectorSep 2017
Kenneth G. LangoneDirectorSep 2017
Michael G. StanskyDirectorSep 2017
Robert S. LangerDirectorSep 2017
Daniel G. EstayDirectorApr 2017
Archibald A. CoxDirectorNov 2016